Table S3.

Individual fold-change for BMP inhibitors in HCC samples.

Sample	FSTL3	GPC3	GREM1	FST
T1_377	1.7	8.9	1.5	2.0
T1_527	2.0	2.2	1.1	1.1
T1_607	2.6	1.6	1.1	0.8
T2_116	1.7	17.2	0.9	4.3
T2_184	1.3	1.7	13.7	1.0
T2_309	1.6	2.5	1.0	1.7
T2_334	2.1	3.6	1.0	1.9
T2_342	0.9	15.4	4.6	3.9
T2_388	3.2	1.9	27.5	0.9
T2_422	1.0	1.7	1.4	2.8
T2_451	2.5	1.8	0.9	1.6
T2_507	1.7	1.3	1.1	1.1
T2_524	2.1	2.7	1.2	1.3
T2_550	1.2	23.5	1.4	3.8
T2_588	1.1	27.7	2.4	1.2
T2_614	1.1	1.1	1.2	2.1
T2_657	1.1	6.3	12.7	1.7
T2_666	1.5	12.4	1.2	1.8
T2_718	1.1	1.0	0.9	1.8
T2_728	1.1	10.9	13.0	1.1
T2_753	3.0	1.5	2.6	0.5
T2_753B	1.8	0.8	1.1	0.3
T2_787	1.2	2.5	1.4	1.7
T2_R2926	1.4	41.5	8.0	6.3
T2_R2927	1.4	1.4	0.9	3.8
T2_R2928	1.3	1.3	1.1	2.9
T2_R2929	1.0	14.3	0.9	2.2
T2_ R3502	2.0	1.9	1.1	0.8
T2_VM3	2.3	3.0	0.9	0.7
T2_VM4	2.7	1.1	1.5	0.7
T3_256	3.2	1.4	0.9	1.4
T3_297	1.5	2.5	1.0	4.4
T3_329	1.2	14.2	1.1	3.1
T3_358	1.8	1.0	1.0	1.4
T3_411	1.1	1.4	6.3	0.9
T3_584	1.4	15.2	1.0	4.2
T3_627	1.1	50.3	1.3	1.8
T4_300	2.1	12.0	1.6	1.9
T4_393	0.9	5.9	3.0	3.3
T4_400	1.2	2.3	1.3	0.7
T4_531	1.2	1.1	1.1	2.6
T4_552	1.0	11.1	0.8	0.8
T4_810	1.5	25.1	1.0	1.8
T4_R2858	1.3	21.3	1.1	4.4
T4A_VM1	2.3	3.0	1.0	1.1
T4B_324	1.0	24.5	0.9	1.3
T4B_353	1.0	1.2	11.1	1.7
T4B_381	1.9	1.6	1.3	1.3
T4B_382	1.5	1.9	1.4	2.2